Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

ClinicalTrials.gov ID: NCT06196879

Public ClinicalTrials.gov record NCT06196879. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study to Evaluate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will evaluate the incidence of asthma exacerbations, other pharmacodynamic (PD) parameters such as lung function and asthma control, and the safety and tolerability of verekitug (UPB-101) compared to placebo.

Study identification

NCT ID
NCT06196879
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Upstream Bio Inc.
Industry
Enrollment
479 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 27, 2024 (Actual)
Primary completion
Dec 16, 2025 (Actual)
Completion
Mar 19, 2026 (Actual)
Last update posted
May 1, 2026

2024 – 2026

United States locations

U.S. sites
55
U.S. states
21
U.S. cities
50
Facility City State ZIP Site status
AllerVie Clinical Research Birmingham Alabama 35209 —
Kern Research, Inc. Bakersfield California 93301 —
Velocity Clinical Research - Lafayette LA Los Angeles California 70508 —
Newport Native MD Inc Newport Beach California 92663 —
California Medical Research Associates Inc. Northridge California 91324 —
Integrated Research of Inland Inc Upland California 91786 —
Allergy & Asthma Clinical Research Walnut Creek California 94598 —
Allianz Research Institute Westminster California 92683 —
Woodland Clinic Medical Group Woodland California 95695 —
National Jewish Health Denver Colorado 80206 —
Advance Pharma Research Cutler Bay Florida 33189 —
Unique Clinical Trials Doral Florida 33172 —
Health and Life Research Institute, LLC Miami Florida 33155 —
Phoenix Medical Research Miami Florida 33165 —
Research Institute of South Florida Miami Florida 33173 —
Nouvelle Clinical Research Miami Florida 33189 —
Anderson Allergy And Asthma, PA Orlando Florida 32806 —
Edward Jenner Research Group, LLC Plantation Florida 33317 —
R&B Medical Center Tampa Florida 33614 —
Clinical Site Partners dba Flourish research Winter Park Florida 32789 —
Clinical Site Partners, LLC dba Flourish Research Winter Park Florida 32789 —
Pivotal Research Solutions Stonecrest Georgia 30038 —
RNA America Health Sciences Sugar Hill Georgia 30518 —
Treasure Valley Medical Research Boise Idaho 83706 —
Velocity Clinical Research - Meridian Meridian Idaho 83642 —
Howard County Center for Lung and Sleep Medicine LLC Columbia Maryland 21044 —
Chesapeake Clinical Research Inc White Marsh Maryland 21162 —
Exordia Medical Research Inc Fall River Massachusetts 02723 —
Pulmonary Research Institute of Southeast Michigan Farmington Hills Michigan 48336 —
AA Medical Research Center Flint Michigan 48504 —
Mayo Clinic Rochester Minnesota 55905 —
M3 Wake Research Las Vegas Nevada 89106 —
Urban Health Plan INC The Bronx New York 10459 —
Advanced Respiratory and Sleep Medicine LLC Huntersville North Carolina 28078 —
Summit Research Group LLC Munroe Falls Ohio 44262 —
Toledo Institute of Clinical Research Inc Toledo Ohio 43617 —
OK Clinical Research, LLC Edmond Oklahoma 73034 —
Portland Clinical Research Clackamas Oregon 97015 —
Velocity Clinical Research - Medford Medford Oregon 97504 —
Velocity Clinical Research - Anderson Anderson South Carolina 29621 —
WR-Notus Clinical Research, LLC Charleston South Carolina 29414 —
Velocity Clinical Research - Spartanburg Spartanburg South Carolina 29303 —
WR-ClinSearch, LLC Chattanooga Tennessee 37421 —
Horizon Clinical Research Cypress Texas 77429 —
Alina Clinical Trials, LLC Dallas Texas 75225 —
AARA Research Center Dallas Texas 75231 —
El Paso Pulmonary Association El Paso Texas 79902 —
Greater Houston Memorial Pulmonary and Sleep Houston Texas 77008 —
Sante Clinical Research Kerrville Texas 78028 —
Mayflower Clinical Marble Falls Texas 02747 —
Metroplex Pulmonary and Sleep Center Drive McKinney Texas 75069 —
Element Research Group San Antonio Texas 78258 —
DM Clinical Tomball Tomball Texas 77375 —
Velocity Clinical Research West Jordan Utah 84088 —
University of Wisconsin--Madison Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 100 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06196879, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06196879 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →